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Using oxygen and NADPH, the redox enzymes cytochrome P450 (CYP) and its reductase
(CPR) work in tandem to carry out the phase I metabolism of a vast majority of drugs
and xenobiotics. As per the erstwhile understanding of the catalytic cycle, binding of
the substrate to CYP’s heme distal pocket allows CPR to pump electrons through a
CPR-CYP complex. In turn, this trigger (a thermodynamic push of electrons) leads to the
activation of oxygen at CYP’s heme-center, to give Compound I, a two-electron deficient
enzyme reactive intermediate. The formation of diffusible radicals and reactive oxygen
species (DROS, hitherto considered an undesired facet of the system) was attributed
to the heme-center. Recently, we had challenged these perceptions and proposed
the murburn (“mured burning” or “mild unrestricted burning”) concept to explain heme
enzymes’ catalytic mechanism, electron-transfer phenomena and the regulation of redox
equivalents’ consumption. Murburn concept incorporates a one-electron paradigm,
advocating obligatory roles for DROS. The new understanding does not call for
high-affinity substrate-binding at the heme distal pocket of the CYP (the first and the
most crucial step of the erstwhile paradigm) or CYP-CPR protein-protein complexations
(the operational backbone of the erstwhile cycle). Herein, the dynamics of reduced
nicotinamide nucleotides’ consumption, peroxide formation and depletion, product(s)
formation, etc. was investigated with various controls, by altering reaction variables,
environments and through the incorporation of diverse molecular probes. In several CYP
systems, control reactions lacking the specific substrate showed comparable or higher
peroxide in milieu, thereby discrediting the foundations of the erstwhile hypothesis. The
profiles obtained by altering CYP:CPR ratios and the profound inhibitions observed upon
the incorporation of catalytic amounts of horseradish peroxidase confirm the obligatory
roles of DROS in milieu, ratifying murburn as the operative concept. The mechanism of
uncoupling (peroxide/water formation) was found to be dependent on multiple one and
two electron equilibriums amongst the reaction components. The investigation explains
the evolutionary implications of xenobiotic metabolism, confirms the obligatory role of
diffusible reactive species in routine redox metabolism within liver microsomes and
establishes that a redox enzyme like CYP enhances reaction rates (achieves catalysis)
via a novel (hitherto unknown) modality.
Keywords: cytochrome P450,murburn, coupling, activation, redox, xenobiotic/drugmetabolism, electron transfer,
reductase
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INTRODUCTION
Tomaintain structural and functional integrity, animals expel the
“deleterious and non-constitutional” extraneous molecules that
enter their system. Xenobiotics are such a category of molecules
and liver, the sentinel organ, deals with them (Testa, 1995). On
the microsome membranes of hepatocytes are found copious
amounts of diverse isozymes of the heme protein cytochrome
P450 (CYP), with much lower distribution densities of a unique
flavoprotein reductase (CPR; Guengerich, 2004; Nelson, 2009;
Xia et al., 2011). Working in tandem, these two proteins carry
out the phase I metabolism of most xenobiotics (Testa, 1995;
Guengerich, 2004). The reaction avails redox equivalents from
NADPH, with oxygen also serving in the overall mixed-function
oxidase scheme. The process may recruit cytochrome b5 (Cyt.
b5) too. Thus, the tetra- or penta-component system localized on
the microsomal membrane attacks xenobiotics, rendering them
more polar (e.g.,—by hydroxylation) or breaking them up into
smaller molecules (e.g.,—by heteroatom dealkylation).
The prevailing mechanistic understanding as per textbooks
(Testa, 1995; de Montellano, 2015), reviews (Guengerich, 2004;
Denisov et al., 2005; Shaik et al., 2005; Poulos, 2014) and
reputable publication portals (Rittle and Green, 2010) is captured
in the sequence of events depicted in Figure 1A. The first and
obligatory step is the binding of xenobiotic substrate at the heme-
pocket of the pertinent CYP. Supposedly, this step changes the
spin state of heme-Fe and increases the redox potential of CYPs
with respect to the CPR. The favorable gradient thus created
serves as a “thermodynamic switch or push,” enabling reduced
CPR to pump electrons to diverse CYPs via long-distance
electron tunneling through the protein-protein complex. Once
the heme-iron center is thus reduced, molecular oxygen binds
there. The oxygen bound at heme-center gets further activated
and forms Compound I, the presumed catalytic intermediate.
Thereafter, with an efficient substrate, a facile “oxygen rebound”
results in substrate hydroxylation. The product thus formed loses
affinity and detaches from the heme-pocket. In the presence
of an “inefficient substrate,” diffusible reactive oxygen species
(peroxide, superoxide, etc.; deemed as deleterious side-products
in this scheme) and water are formed at the heme-center and
released subsequently.
It is difficult to envisage that a plethora of xenobiotics (of
varying dimensions, topographies and surface electrostatics)
could stay “committed to catalysis” (Lu, 1998) by remaining glued
to the same heme-pocket for protracted time-frames. For the lack
of significant affinity-based causatives, the erstwhile cycle looked
too “deterministic” (Venkatachalam et al., 2016). Protein-protein
or protein-small molecule complexes/crystals may spontaneously
Abbreviations: 4′OH or 4′OH Diclof, 4′hydroxydiclofenac; 7EFC, 7-
ethoxytrifluoromethylcoumarin; 7HFC,7- hydroxytrifluoromethylcoumarin;
ABT, aminobenzotriazole; CPO, Chloroperoxidase; CPR, Cytochrome P450
Reductase; CYP, Cytochrome P450; Cyt. b5, Cytochrome b5; Cyt. c, Cytochrome c;
Czx, Chlorzoxazone; Diclof, Diclofenac; DLPC, Dilauroyl Phosphatidyl Choline;
(D)ROS, (Diffusible) Radicals and Reactive Oxygen Species; HRP, Horseradish
peroxidase; NAD[P_H, Nicotinamide Adenine Dinucleotide (Phosphate)
reduced]; Pdr, Putidaredoxin Reductase; pNP, p- Nitrophenol; rxn., Reaction;
SOD, Superoxide Dismutase; Vit C, Vitamin C; Vit E, Vitamin E; Warf, Warfarin.
form when water is removed from a system comprising of
hydrophobic elements. We argued that there is little evidence for
the functional roles of such complexes in situ (Venkatachalam
et al., 2016). Further, when the enzymes and reactants are taken
in vitro at nM and µM ranges respectively, we could observe
specific product formation at high rates, in the range of ∼0.1–1
s−1 (pseudo-first order), which is unaccountable by the erstwhile
hypothesis’ multi-molecular and ordered sequence of events.
Based on such evolutionary/chemical logic, diffusion/collision
argument, some meta-analyses of kinetics data and in silico
evidences (Venkatachalam et al., 2016), mechanistic findings
on a polar heme-thiolate fungal enzyme chloroperoxidase
(CPO; Manoj, 2006; Manoj and Hager, 2008), fundamental
revamping of the mechanism of electron transfers in protein-
protein and protein-small molecules (Andrew et al., 2011;
Gade et al., 2012; Parashar and Manoj, 2012; Parashar et al.,
2014b; Manoj et al., 2016a,b) and some preliminary results
on the CYP + CPR reaction systems (Manoj et al., 2010a,b;
Gideon et al., 2012; Parashar et al., 2014a), we had proposed a
“radical” (pun intended!) explanation with the murburn concept
(Venkatachalam et al., 2016;Manoj et al., 2016b). Key elements of
this “constitutive” paradigm are depicted in Figure 1B. Herein,
the presence of CPR generates one-electron redox equivalents
fromNADPH, which is relayed to the CYP (via diffusible radicals
like superoxide OR non-specific electron relays can reduce
the heme-center via the proximal thiolate port, and molecular
oxygen could coordinate at the distal site thereafter), resulting in
the stabilization of a one-electron species (like Fe-superoxide),
at the heme-center. The xenobiotic substrate, transiently bound
(before/after the radical stabilization event) anywhere on the
CYP has an enhanced probability to react with the intermediate,
within/on/around the CYP. This scheme is unordered and all
steps are bimolecular. The current manuscript probes steps 1
through 3 of the erstwhile hypothesis, explores the complexities
of the reaction milieu and checks key predictions we made earlier
(Venkatachalam et al., 2016), to ratify the murburn concept’s
applicability to CYP+ CPR systems.
MATERIALS AND METHODS
Most details of materials and methods employed in the
current study are standard protocols that have been described
previously/recently in our manuscripts (Manoj et al., 2010a,b,
2016b; Parashar et al., 2014a; Parashar and Manoj, submitted).
Materials
CYP3A4 (P2377), CYP2D6 (P2283), CYP2E1 (P2948), and
CYP2C9 (P2378) baculosomes were procured from Invitrogen
(PanVera) and a CYP2C9 baculosome was from Merck
(#011902). The activity of CYP2C9 and CYP2E1 baculosomes
agreed with the statement provided by the supplier. The details
of composition are available from the manufacturers’ website. A
pure CPR prep was also procured from Invitrogen (currently,
Thermofisher, P2309). CPO was a gift from the late Lowell Hager
(UIUC) and SOD, catalase, HRP, myoglobin and hemoglobin
were purchased from Sigma. The sources of pure proteins (CYPs
and CPR, prepared from cDNAs) are the same as described in our
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FIGURE 1 | Schema of old and new hypotheses explaining CYP + CPR mediated xenobiotic metabolism. The presence of NADPH is implied. RH and ROH
stand for substrate and product, respectively. Asterisk is used to indicate an activated species. (A) The erstwhile “textbook” CYP + CPR catalytic cycle: The
thermodynamic switch is a CPR-based push that is dependent on substrate binding to CYP. All events leading to product and DROS formation require the substrate
bound to CYP. (B) The newly-proposed murburn concept: Substrate is required only in the last step, there are no protein-protein complexations and all reactions are
randomized and bimolecular. The electron sink afforded by substrate hydroxylation or ROS depletion serves as a redox pull at right.
earlier works (Manoj et al., 2010a,b). Chemicals (of AR grade)
were from Sigma-Aldrich, Lancaster or Alfa-Aesar.
General Protocols
In order to gain kinetic and stoichiometric insights, the CYP +
CPR reaction was approached in two modalities- (i) A simple
laboratory reconstituted system comprising of a mixture of
purified proteins (CYP and CPR) at known concentrations in
phospholipid micelles or vesicles and (ii) The commercially
available baculosome system in which CYP and CPR (and when
needed, Cyt. b5) are co-expressed using baculoviral infection
of insect cells. Usually, in baculosomes, CPR is in excess of
the actual concentrations present in liver microsomes and these
preparations are optimized to ensure high catalytic activity of the
CYPs. The dynamics of electron transfer in CYP+ CPR reaction
systems can be studied at four levels- consumption of oxygen,
disappearance of NAD(P)H, production of superoxide/peroxide
(diffusible reduced oxygen species or DROS) and conversion
of the final substrate to product(s). To minimize experimental
variables, the reactions were carried out in aerated vials. Since
superoxide equilibrates with peroxide and it is experimentally
difficult to quantifiably differentiate their absolute concentrations
in a mixture, only the latter was assayed. To minimize the
wastage of expensive NAD(P)H in routine experimentations,
stocks prepared on first day were used within the next few days
also. Therefore, the reactions may have contained up to 20%
excess NAD(P)+, in conjunction with the actual initial value of
NAD(P)H quoted.
The concentrations of CYP stocks (commercial sources and
membrane fractions) were determined by CO binding spectra
(Omura and Sato, 1964). CPR and NADPH were quantified
spectrophotometrically at 550 nm (Pritchard et al., 2006) and
340 nm (Stocchi et al., 1985), with molar extinction coefficients
of 21000 and 6220, respectively. The absolute concentration
of a commercial peroxide stock was determined by titanium
complex formation (Sellers, 1980), which is more accurate than
the UV spectrophotometric estimation procedure at ∼240 nm.
The standardized peroxide stock was then used for preparing
the standard plot (of micromolar levels of peroxide) and for
estimation of unknown concentrations by Peroxoquant method
of Pierce chemicals (Jiang et al., 1990). The standard plot was
repeated for each set of samples analyzed, since older reagents
gave lower slopes. Peroxide concentration assays were very
precise and accurate (∼5% standard deviation) with respect
to samples drawn from the same vial; however, the standard
deviations were generally higher when a reaction was duplicated
in another vial. Unless otherwise mentioned, all incubations were
done in aerated open vials at 37 ± 1◦C in 100mM phosphate
buffer, pH 7.4 and reconstituted systems had 10µg/ml of 0.2µm
vesicles of dilauroyl phosphatidylcholine (DLPC, Avanti Lipids).
The details of HPLC analysis is given in our earlier works (Manoj
et al., 2010a). The data points obtained with fluorescence analysis
of HFC (Kenaan et al., 2010) correlated well with the HPLC
method. In silico protocols employed herein have been previously
described (Venkatachalam et al., 2016). Other specific details
and the initial conditions of assays are listed in the pertinent
legends. Values reported are means and standard deviations from
duplicate or triplicate assays.
Inclusion of Excess Redox-Active
Heme-Proteins and Dyes
At 5 nM (Invitrogen) CYP2C9, 100µM diclofenac and 125µM
NADPH, 25–125 nM of myoglobin/hemoglobin (Met-Mb/Met-
Hb, both of which have a far higher positive value of
redox potentials when compared to CYPs) were incorporated.
At 15min incubation, ∼1.15 nmoles/ml 4′hydroxydiclofenac
(4′OH diclof) and ∼2.2 nmoles/ml peroxide were formed in
the control reaction, which consumed NADPH at a rate of
0.225 nmoles/ml/min. The test samples gave a slight increase in
NADPH consumption (∼10%) andMet-Hb reduced the product
whereas Met-Mb increased the product (both by less than 5%),
and incorporation of both proteins lowered peroxide in milieu.
Excess of small redox-active dyes of varying single and double
electron redox potentials like- positively chargedmethyl viologen
(Eo
′
∼ −446mV) and phenosafranin (Eo
′
∼ −273mV) and
negatively charged anthraquinone disulfonate (Eo
′
∼ −184mV)
and indigocarmine (Eo
′
∼ −125mV) -were incorporated into
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baculosome and reconstituted systems exhibiting comparable
hydroxylation efficiencies. Initial concentrations were- 200µM
diclofenac, 1mM NADPH and redox sensitive dyes were at
2µM. Reconstituted system and Merck baculosome preparation
reactions were carried out at 200 nM (CPR was ∼400 nM) and
10 nM, respectively for CYP2C9. The test samples incorporating
the redox sensitive small molecules showed only∼10% variations
from the control for the hydroxylation of diclofenac by
CYP2C9 in both the reaction setups (after 30min’ incubation,
2.8 nmoles/ml for reconstituted setup and 4.9 nmoles/ml for
baculosomes).
Hydroxylation without Protein-Protein
Complexation
Stock solutions of 8µM pure CYP2C9, 3µM pure CPR, 200mM
Diclof sodium, 100mMNADPH and 20% v/v glycerol weremade
in 100mM potassium phosphate buffer, pH 7.4. The test reaction
was conducted in a 2+4ml mixture. The 2ml taken in the
dialysis tubing (Spectra/Por, 12–14 KD cutoff) had 150µl of pure
CYP2C9, 200µl of Diclof, 40µl of NADPH, 300µl of glycerol-
buffer, and 1310µl of buffer. The 4ml taken in free solution had
800µl of pure CPR, 600µl of Diclof, 120µl of NADPH, 900µl of
glycerol buffer and 3580µl of buffer. The positive control (1ml)
reaction had 18.8µl of CYP2C9, 100µl of CPR, 20µl of NADPH,
150µl of glycerol buffer and 611.3µl of potassium phosphate
buffer. The reactions were gently stirred with a magnetic paddle
and incubated for 45min at 37 ◦C.
Simulation of CYP-CPR Activity with
CYP2C9-DROS
Superoxide stock for this experiment was prepared as follows-
∼5mg of KO2 was weighed and dissolved in 700µl of 50:50
dimethyl sulfoxide (DMSO) and 18-crown ether to give a
superoxide stock solution of ∼100mM concentration. 2µl of
this solution was added to 300µl of 50:50 DMSO and 15-crown
ether to give a KO2 solution of ∼667µM. 10µl of this sub-stock
was added to 400µl of the reaction. Therefore, the reaction also
had ∼1% DMSO and 15-crown ether. It is important to note
that the actual initial concentration of superoxide may have been
much lower than 16µM, because superoxide readily absorbs
moisture (while weighing out and from the DMSO added). The
water molecules provide sufficient protons for the formation of
peroxide from superoxide (Sawyer and Valentine, 1981).
RESULTS
Effect of Substrate and Various Reaction
Components on Peroxide Dynamics in
milieu
Figure 2 shows the time course profiles for peroxide in milieu for
CYP3A4, CYP2C9, CYP2E1, and CYP2D6 baculosomes; with
or without their “specific” substrates testosterone, diclofenac,
chlorzoxazone, and dextromethorphan, respectively. Most
time points showed somewhat lower or similar peroxide
concentrations with respect to the pertinent controls lacking
the substrate. Also, peroxide concentration lowered after an
increase, or varied rather unpredictably over time. Figure 2B
shows similar results for peroxide profiles for two sources of
baculosomes and varying concentrations of reconstituted pure
protein setups of CYP2C9± diclofenac. Figure 2C compares the
effect of NADPH concentrations in the CYP2C9 reconstituted
system. While the initial rates of hydroxylation do not change
by increasing NADPH from 0.1 to 1mM, the peroxide profiles
are found to differ. At later time points, lesser hydroxylated
product is noted at low concentrations of NADPH in the
reconstituted system. Comparatively, baculosomes showed
similar profiles for substrate hydroxylation and peroxide
formation, in both cases (results not shown). Time profiles and
analyses of reaction stoichiometry for two CYP2C9 reaction
setups, along with the chemical control, are shown in Figure 3
and Table 1. Linearity could be noted for NADPH depletion
for all setups into micromolar ranges, indicating a zeroth order
dependence (or consumption via radical route). As the reaction
progressed, peroxide:NADPH and product:NADPH ratios
lowered whereas water:NADPH ratio increased. In the test
reactions, peroxide:product ratio decreased and water:product
ratio increased over time. These aspects of the reaction
phenomenology clearly establish the inapplicability of the
erstwhile hypothesis and indicate multiple redox equilibriums in
milieu.
To understand the dynamics of DROS in the penta-
component CYP + CPR reaction system (besides the two key
enzymes, NADPH, molecular oxygen and the substrate molecule
constitute the fiveminimal components), the reaction systemwas
studied for peroxide formation, with a lesser number of variables.
From Figures S1, S2 (Supplementary Information), it can be
noted that peroxide formation dynamics was dependent on the
type of substrate present in several types of controls (CPR +
Substrate + NADPH, Fe + NADPH + Substrate, Substrate +
Superoxide, etc.). The role of substrate serving in modulating
the DROS dynamics on its own merit is hereby brought
forth. A unidirectional correlation of peroxide formation with
progression of time cannot be seen in these cases, quite similar
to the complex CYP reaction system. When lesser amounts of
ferric citrate was used, the detectable concentration of peroxide
went down (along with the NADPH consumption rate; results
not shown). From Figure S2 (Supplementary Information),
we can infer that addition of excess superoxide (stabilized in
DMSO) did not translate into peroxide even within the first
few minutes of reaction initiation, indicating that superoxide
to water conversion was very efficient under these conditions.
Figure S3 (Supplementary Information) probes the ability of
various reaction components’ roles in depletion of DROS. When
100µM peroxide was presented initially to various controls,
it was seen that all reaction components have the ability to
modulate the dynamics of ROS. The setups with CYPs showed
the lowest peroxide depletion and NADPH + peroxide showed
the highest peroxide dismutation. When we added 10 times more
CYP2C9 and brought it to 400 nM, the peroxide concentration
was highly stable for a prolonged time (result not shown).
This observation indicates that CYPs stabilize the one-electron
equivalents generated in milieu, which otherwise react with
peroxide (or among themselves) to form water. It counters the
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FIGURE 2 | The effect of substrate on peroxide profile in milieu for different CYP reaction setups: Unfilled points are reactions with substrates
whereas the filled points lack substrates. At 15min incubation, the specific product in CYP2C9 systems ranged from 0.02 to 10 nmoles/ml. (A) Peroxide profiles
in various CYP baculosomes: Initial conditions- [NADPH] = 2mM and [CYPs] = 20 nM. Substrates, when present, were at 200µM. (B) Peroxide formation in various
reaction setups of CYP2C9: Reactions contained 1mM NADPH and 200µM Diclof. (C) Effect of NADPH on peroxide profile in reconstituted CYP2C9 systems: Initial
conditions- [Diclof.] = 200µM, [CYP2C9] = 20 nM and [CPR] = 250 nM. At 15 and 30min incubation, the reaction with 1.0mM or 0.1mM NADPH gave 0.14 or
0.13 nmoles/ml and 0.27 or 0.20 nmoles/ml 4′hydroxydiclofenac, respectively.
FIGURE 3 | Temporal profiles for reactants and products in a simple CYP + CPR reaction system: (Key: ©- chemical, - reconstituted, △-
baculosome). Initial concentrations of components were- [Diclof.] = 200µM, [NADPH] = 180µM. [CYP2C9] = 10 nM. In reconstituted system, CPR was
taken at ∼0.6µM.
presumption that CYPsmake water at the heme-center. Figure S4
(Supplementary Information) shows that polar ROS scavengers
(taken at mM levels) could also deleteriously affect the peroxide
depletion activity of CPR (a novel finding we had recently
reported; Manoj et al., 2010b). All these observations indicate
the presence of intricate redox equilibriums in the reaction
system (within both lipid and aqueous microenvironments) and
accounts for the chaotic ROS profiles observed in CYP reactions.
The findings challenge the prevailing notion that activation of
molecular oxygen and generation (or depletion) of ROS primarily
occurs at the heme-center.
Effect of Varying the Ratio of CYP and CPR
on Reaction Stoichiometry/Yield
If we were to consider the erstwhile hypothesis as the “binding”
principle, increasing CYP or CPR concentration should give
more of CYP-CPR collisions and complex formation, which
should enhance their functional outcomes in a predictable
manner. Figure 4 shows the de-ethylation profiles of a coumarin
derivative. When CYP1A2 was varied at a constant CYP +
CPR concentration, it resulted in asymmetric curves (left panel).
Optimal activities were observed in the range of 0.47 to 0.73
mole fraction of CYP1A2. Varying CYP (at a constant CPR
concentration of 25 or 50 nM) gave a sigmoid curve with
high amplitude. Whereas, varying CPR (at a constant CYP
concentration of 25 or 50 nM) resulted in hyperbolic curve with
much lesser amplitude (middle and right panels of Figure 4).
Reactions at 25 nM CYP + 100 to 250 nM CPR showed almost
an order lesser activity than 25 nM CPR + 100 to 250 nM CYP
(middle panel of Figure 4). Overall, the results do not indicate
any definite complexation stoichiometry. Furthermore, pre-
incubation time showed profound impact on the specific product
formation at diverse concentration ranges of both enzymes (right
panel of Figure 4). This finding dismisses any suggestions that
collisions are “effective” amongst the proteins in the phospholipid
microenvironment. The data imply that more CYPs per a given
CPR concentration enhance the probability for the former to
trap the radical intermediates released by the latter. With more
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TABLE 1 | Comparison of relative stoichiometries of a reconstituted and baculosome system.
Rxn. NADPH (nmoles/ml/min) H2O2/NADPH (%) Prdt./NADPH (%) Water/NADPH (%) H2O2/Prdt. Water/Prdt.
Baculosome 0.191 ± 0.01 43*, 0 57, 50 0, 50 0.75, 0 0, 1
Reconstituted 1.936 ± 0.05 61, 25 0.2, 0.1 39, 75 339, 278 217, 833
Autocatalysis 0.070 ± 0.02 100*, 0 ∼0, ∼0 0, 100 ∞,∞ ∞,∞
The absolute peroxide concentrations in baculosome, reconstituted and autocatalytic systems were (2.1, 0), (17.7, 28.9) and (1.1 and 0) nmoles/ml, respectively at 15 and 60min.
Specific hydroxylated product formed was (1.66, 5.71) and (0.053, 0.11) nmoles/ml for baculosome and reconstituted systems, respectively at 15 and 60min. Calculation of water
formation was: NADPH consumed − (product formed + peroxide formed). Initial conditions are given in the legend to Figure 1. (*slight overshoot in peroxide estimation is noted).
CPR per CYP, the reaction is uncoupled, as the diffusible species
end up reacting among them. The effect of varying the CPR to
CYP2C9 ratio on the reconstituted reaction system was studied
in two independent experiments and the results are presented
in Figure 5. NADPH consumption rates and peroxide formation
depended on the concentration of CPR. At low CPR:CYP
ratios, NADPH consumption/peroxide formation profiles of
the reactions incorporating good (diclofenac, Diclof) or poor
(warfarin, Warf) substrates did not show major differences and
fell in a comparable range, much like the appropriate controls
lacking the substrates (Figure 5A). Figure 5B reconfirms the
interesting finding seen earlier that the overall yield of
hydroxylated product vs. NADPH equivalents consumed was
higher for low CPR:CYP2C9 ratios, as was also noted for
the CYP1A2 de-ethylation reactions. Coupled with our recent
revelations that electron transfer between such redox proteins
occurs via non-specific relays (Gade et al., 2012; Manoj et al.,
2016a), the profiles obtained herein discredit the erstwhile
hypothesis and support themurburn concept.
Effect of Incorporation of Diverse Additives
to Probe the Electron Transfer Mechanism
in Reaction Milieu
Addition of excess (∼5–25-folds) of myoglobin and hemoglobin
(mammalian soluble heme proteins offering a better redox
potential gradient than CYPs) to the CYP2C9 + CPR mixture
did not significantly alter the NADPH consumption or product
formation rates. When excess (∼10–200-folds) of positively
or negatively charged redox-active dyes were incorporated in
a reconstituted or baculosome reaction system of CYP2C9,
the hydroxylation efficiency was not perturbed (For the two
statements above, the details are given in Methods Section
Inclusion of Excess Redox-Active Heme-Proteins and Dyes).
Also, the CYP + CPR reaction functions effectively in spite of
the addition of copious amounts of non-redox sensitive proteins
like bovine serum albumin and chick albumin. If protein-protein
electron transfer mechanisms were involved, one would expect
some inhibition owing to non-specific binding of extraneous
proteins on to the reactive proteins’ surfaces. These (negative)
observations, coupled with the findings from Figures 4, 5,
downplay the role of protein-protein complex formations and
their purported electrostatic interactions for electron transfers in
milieu.
In Figure S5 (Supplementary Information), it is shown that
excess of sulfur-atom containing redox-active small molecules
can also affect NADPH consumption, peroxide formation (not
shown) and specific product formation (although not in a very
profound manner). For example-enhancement of up to 35%
NADPH consumption and 15% increase in specific product
formation was noted with the incorporation of glutathione.
Also, non-linearity (with respect to time) in product formation
or NADPH consumption could be noted. We had recently
reported the effects of incorporation of two ROS scavenging
vitamins in CYP2C9 reactions- the fat-soluble Vitamin E and
the water soluble Vitamin C (Parashar et al., 2014a). Figure
S6 (Supplementary Information) shows the temporal effects
of these vitamins and their derivatives of these vitamins on
product formation in two setups- baculosomes and microsomes.
We had reported earlier that the water-soluble antioxidant
vitamins were less effective, the amphipathic ROS scavengers
could effectively inhibit CYP2C9mediated hydroxylation in both
setups, thereby confirming the obligatory role of ROS in the
reaction. It can be seen herein that advent of time changes the
dynamics (of ROS and thereby, product formation) in reaction
milieu. For example- (i) though Vit. C (in microsomes, at 1mM
concentration) inhibits diclofenac hydroxylation significantly at
10min, the effect wears off at later times. (ii) Vit. E inhibits
CYP2C9 baculosome activity completely (in baculosomes, at
0.1mM concentration) when sampling is done at 10min, but a
significant activity is observed when sample was withdrawn at
15min. These effects are in line with some of our simulation
studies (Figures 6, 7 of the current study and in other reactions
with CYP2E1; Parashar and Manoj, submitted).
The effect of inclusion of DROS utilizing proteins on CYP2C9
mediated hydroxylation of diclofenac is presented in Table 2
and the pertinent chromatograms are shown in Figure S7,
Supplementary Information. Inclusion of superoxide dismutase
(SOD) and catalase lowered the consumption of NADPH,
without significantly affecting the hydroxylations at earlier time
points. At later time points, the product yield was higher in
reaction mixtures containing catalase and SOD. This is because
SOD and catalase lowered secondary oxidations, by removing
superoxide and peroxide (respectively) from the aqueous milieu.
Chloroperoxidase (CPO) is dysfunctional at pH ≥ 7.0 (where
it is ineffective at utilizing DROS) and therefore, it did not
significantly affect the reaction profiles in the presence of
diclofenac (quite akin to the effects shown by myoglobin
and hemoglobin). When CPO was incorporated at pH 6.2
(where it is active) and compared with reactions at pH 7.4,
significant reduction of hydroxylation was not seen (Figure S8,
Supplementary Information). This could perhaps be because of
a glutamate residue located quite adjacent to the heme iron,
which could lower the superoxide utilization ability. It was
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FIGURE 4 | Searching for functional evidence of CYP-CPR complex formation: Initial conditions were- 20µM DLPC, 40 or 50µM 7EFC, 500µM NADPH,
0–500 nM CPR or CYP1A2 as titrants. For the left panel, rates were calculated from slope of line obtained by the estimation of product at 3, 6, and 9min, respectively.
For the middle and right panel, reaction sampling was done at 12 and 10min, respectively.
FIGURE 5 | Monitoring reaction dynamics by varying CPR to CYP ratios in a reconstituted system: (A) Initial reaction conditions- [CYP2C9] = 100 nM,
[NADPH] ∼160µM and [substrates] = 200µM. Maximal NADPH autocatalytic rates under these conditions were ∼0.1 nmoles/ml/min. CYP alone gave ∼0.2 and
CPR alone gave ∼0.3 nmoles/ml/min, respectively. (B) Initial reaction conditions were [CYP2C9] = 100 nM, [NADPH] ∼200µM, and [substrates] = 200µM.
interesting to note that NADPH consumption was higher at pH
6.2 (irrespective of the presence of CPO) but hydroxylations were
relatively inefficient. In another experiment (with 200µMDiclof,
160µM NADPH, CYP2C9 baculosome −25 nM of CYP), the
effect of pH was probed at 3 values- 7.0, 7.4, and 8.0. At an
early time frame of 5min, approximately 12µM NADPH was
consumed and 0.3µM peroxide was detected in all the three
reactions. However, the specific product formation was 2.68, 2.15,
and 1.15µM at pH 7, 7.4 and 8 respectively. At later times, pH
8 showed slightly higher NADPH utilization and significantly
greater uncoupling (profile not shown). The observations signify
the roles of protons and hydroxyl ions affecting the overall
equilibriums.
Remarkably, inclusion of horseradish peroxidase (HRP)
increased NADPH by many folds; whereas CYP2C9 mediated
diclofenac hydroxylation was completely inhibited (Table 2).
In Table 3, the detailed investigation into HRP’s intriguing
inhibitory effect is shown. The inclusion of HRP took away the
peroxide in milieu, leading to very high NADPH consumption.
HRP is an enzyme that effectively uses both peroxide and
superoxide. In conjunction with our findings on the inhibition
of CPR-mediated electron transfers by diverse one-electron
redox-active agents (Manoj et al., 2016a) and inhibition of soluble
heme enzymes’ (Parashar et al., 2014b; Manoj et al., 2016b)/CYPs’
(Gideon et al., 2012; Parashar et al., 2014a) activities (by various
polar and amphipathic DROS- scavengers, respectively), the
functional role of diffusible radical species is hereby confirmed in
such systems. It can be seen from the controls that the substrate,
on its own merit (and in conjunction with the enzymes), can
also affect the DROS profiles. This inference was confirmed
in another experiment (Supplementary Information, Figure S9)
carried out at 27 ◦C for 1 h, with a commercially available CPR
prep, with fully intact N-term trans-membrane peptide. Lower
amounts of peroxide generation (<1µM in all setups) was
seen in milieu. The obvious inference from both experiments
is that both CPR and HRP can utilize NADPH; however, when
used in tandem, they yield a hyper-concerted effect, which is
significantly augmented by the presence of the substrate. HRP
is highly efficient at inhibiting the reaction because it has a
high spin Fe (which can flip triplet oxygen to the singlet state!)
and it has positively charged amino acids in the active site (His
42, Arg 38 etc., which can better utilize superoxide). Further,
it possesses a hydrophobic transmembrane helix on one end
(Figure S10 and Table S1, Supplementary Information), which
would enable it to compete effectively with CYP. HRP is a fungal
enzyme, 325 amino acids long. HRP has only 4% query coverage
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FIGURE 6 | Demonstration of nonspecific partnering with diverse combinations of P450cam, reductases, auxiliary redox partners, substrates and
electron donors: All the reactions were carried out at 27 ± 1◦C in 100mM potassium phosphate buffer (pH 7.4). The initial concentration of substrate employed was
200µM. Enzyme concentrations were as follows: [P450cam] = 0.5µM and [Pdr] = 0.6µM. Electron donors: [NADH] and [H2O2] = 1mM, [O
.−
2 ] = 50µM. [Cyt. c] and
[Vit. C] = 1µM. (A) P450cam reactions with pNP (a CYP2E1 marker substrate), employing Pdr and NADH as redox equivalent generating agents. The control had only
pNP, P450cam, Pdr, and NADH. (B) Schematic of HPLC profiles obtained with P450cam and coumarin (a CYP2B6 substrate), employing superoxide as the sole redox
agent. The inset to the right shows the original area under curve (AUC) values obtained.
FIGURE 7 | Demonstration of nonspecific partnering with diverse combinations of CYPs, reductases, auxiliary redox partners, substrates and electron
donors: All the reactions were carried out at 27 ± 1◦C in 100mM potassium phosphate buffer (pH 7.4). The initial concentration of substrate employed was 200µM.
Enzyme concentrations were as follows: [CYP3A4] and [CYP2C9] = 0.1µM and [Pdr] = 0.6µM. Electron donors: [NADH] and [H2O2] = 1mM, [O
.−
2 ] = 50µM. [Lipid]
= 0.5µg DLPC/pmole P450. (A) CYP3A4 reactions with coumarin. (B) P450BM3 reactions with coumarin (the control lacked any added reductant). (C) CYP2C9
reactions with coumarin.
(BLAST) with respect to the 490 amino acids long CYP2C9.
Binding of diclofenac to the enzyme and associated spin change is
also inconsequential herein (Supplementary Information, Figure
S10). Therefore, CPR-HRP electron transfer by protein-protein
complexation (based on a substrate-binding mechanism) can
be sidelined. This result provides profound insight into the
“redox pull” mechanism operative in the CYP + CPR milieu,
quite akin to peroxidases (Manoj et al., 2016b). The findings
lend solid support to the murburn concept’s relevance in CYP
catalysis.
Simulation of CYP Activity with Non-
conventional Redox Partners and
Substrates, Sans CPR
We had predicted that if CYPs’ activity entailed the involvement
of radicals/DROS, it should be facile to simulate the reaction
without CYP-CPR complexations, with CYPs and DROS alone
(Venkatachalam et al., 2016). Separating the two proteins by
a dialysis membrane gave ∼1.6% of the specific hydroxylation
activity given by the fully mixed system (Supplementary
Information, Figure S11, left panel). The lower yield is because
in such a scenario, CYP is not present in close enough proximity
to latch on to the superoxide or one-electron equivalents
unleashed by CPR. Therefore, it is lost to the aqueous milieu,
where superoxide dismutates to peroxide (which is a poor
activator of CYPs). This inference is confirmed with the fact
that it was also possible to efficiently mimic the specific
hydroxylation of CYP2C9-diclofenac with stabilized superoxide
alone, but not with peroxide (Table 4). This result is quite
along the simulation of CYP2E1 activity for pNP substrate
(Parashar and Manoj, submitted). Interestingly, when secondary
oxidation of diclofenac was probed, it was seen that the
original substrate was inefficient at inhibiting the reaction
(Supplementary Information, Figure S11, middle and right
panels), which negated the “loss of affinity upon hydroxylation”
understanding afforded by the erstwhile paradigm.
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TABLE 2 | Effect of DROS utilizing proteins on CYP2C9 reactions.
Item CYP2C9 only CYP2C9 + CPO CYP2C9 + Cat CYP2C9 + SOD CYP2C9 + HRP
NADPH rate (- Diclof) 0.35 ± 0.03 1.05 ± 0.02 0.43 ± 0.04 0.39 ± 0.01 4.76 ± 0.07
NADPH rate (+ Diclof) 1.63 ± 0.1 1.77 ± 0.1 0.37 ± 0.08 0.63 ± 0.02 5.97 ± 0.13
4′OH Diclof at 15min 0.52 ± 0.03 0.54 ± 0.03 0.52 ± 0.04 0.6 ± 0.04 0
4′OH Diclof at 30min 0.69 ± 0.05 0.71 ± 0.06 0.82 ± 0.07 0.97 ± 0.04 0
4′OH Diclof at 60min 0.48 ± 0.06 0.40 ± 0.04 1.18 ± 0.09 1.41 ± 0.08 0
Initial concentrations were- [NADPH] = 160µM, [CYP2C9] ∼50 nM, [CPR] ∼150 nM, [Diclof] = 200µM. The proteins procured from commercial sources were added at 0.1–0.5 mg/ml
of reaction. NADPH consumption was determined from the slope of linear fit of OD (at 340 nm) at 0.25, 15, 30, 45, and 60 min (except for the reactions containing HRP, for which only
the first three points were taken, because all of the NADPH had practically depleted within 30min). Rate of consumption of NADPH (nmoles/ml/min); 4′OH diclofenac (nmoles/ml).
TABLE 3 | Effect of HRP on NADPH consumption and peroxide generation.
Rxn.→ NADPH only NADPH + HRP NADPH + CPR NADPH + HRP + CPR
−Diclof +Diclof −Diclof +Diclof −Diclof +Diclof −Diclof +Diclof
NADPH 3.9 ± 0.9 4.2 ± 0.6 12.3 ± 0.9 15.9 ± 1.5 14.4 ± 0.3 15.4 ± 1.4 83.4 ± 2 113 ± 3
Peroxide 0.5 ± 0.2 1.3 ± 0.3 <0.5 0.8 ± 0.3 13.3 ± 1 12.2 ± 0.3 <0.5 1.3 ± 0.2
Diclofenac and NADPH were taken at 200µM whereas CPR and HRP were at 100 nM each. NADPH-nmoles/ml of the molecules consumed (in 30min); Peroxide-nmoles/ml formed
(at 30min).
TABLE 4 | Simulation of hydroxylating activity of CYP2C9 with DROS.
Reaction Without
CYP2C9
With
CYP2C9
CPR+NADPH Trace 911
H2O2 <10 ∼41
O2
·− ∼112* ∼995*
Concentrations of specific 4’hydroxylated diclofenac formed after 10 min incubation
(followed by termination of the reaction with the stopping agent) are given in nM.
Initial concentrations of the reaction components were- [Diclof] = 25 µM, [DLPC] =
20 µM, [CYP2C9] = 100 nM. When present, the initial concentration of the following
components was—[NADPH] = 200 µM, [CPR] = 200 nM, [H2O2 ] = 32µM, [KO2 ] ≤
16µM. *Non-specific hydroxylations or side reactions were noted.
P450cam gave poor query coverage (41%) or maximum
identity (26%) with respect to CYP2E1. In Figure 6A, P450cam
was used to hydroxylate pNP, a CYP2E1 substrate. In the control,
only P450cam and Pdr were used with pNP and NADH; but, this
mixture failed to give the product. In the test reactions, Cyt. c
and vitamin C were employed instead of putidaredoxin (Pdx,
the classic redox relay protein in the Pseudomonas system). Both
redox active molecules effectively supported P450cam mediated
hydroxylation of pNP. Further, secondary oxidations were found
to be contingent on the type and amount of redox additives
present. For example- µM levels of Cyt. c gave efficient pNC
at initial timeframes but also took away the product at later
times. In comparison, nM levels of Cyt. c gave pNC only at
later time frames, indicating a hastened product formation owing
to the change in ROS species in the reaction milieu with the
advent of reaction. When coumarin was used as a substrate for
P450cam with superoxide, the 7′OH product could be formed,
although other side products were also noted (Figure 6B). This
is when the reaction of superoxide with coumarin alone did
not give significant 7′OH product formation but produced more
polar products that eluted upstream (perhaps, owing to multiple
hydroxylations).
The results for hydroxylation of coumarin with other CYPs
are shown in Figure 7. Coumarin is usually metabolized by
CYP2B6 in liver microsomes. CYP3A4 could hydroxylate this
substrate using Pdr + NADH or H2O2 (Figure 7A). Even
P450BM3 was able to hydroxylate the substrate to give 7’
hydroxycoumarin (Figure 7B). Besides this specific reaction,
product A was obtained (possibly hydroxylation at a different
carbon, gauging from its elution time in HPLC) in P450BM3 and
CYP2C9 reactions (Figure 7C). Quite alike CYP3A4, CYP2C9
also afforded coumarin conversion with Pdr as the redox partner
(in conjunction with NADH ± H2O2). It is highly unlikely
that any specific protein-protein complexation modality would
be operative in these reaction mixtures, considering the extent
of differences in structural and topographical attributes of the
proteins/molecules substituted herein. CPR and Cyt. b5 gave a
query coverage of 7 and 37%, respectively and maximum identity
of 54 and 25%, respectively (by BLAST analysis) with respect to
Pdr and Pdx. These findings also confirm that redox equilibriums
evolve and change during a CYP+ CPR reaction “in the pot.”
The Effects of Reduced Nicotinamide
Nucleotides and Cytochrome b5
Table 5 presents the effect of NAD(P)H on peroxide formation
in reconstituted system, with appropriate controls. Peroxide
formation increases with time and with NAD(P)H concentration
in most of the cases. In the initial time frames, the rate of
NAD(P)H consumption and peroxide production increased in
the sequence CYP ± diclofencac, CPR ± diclofencac, CYP +
CPR, and CYP + CPR + diclofencac. CYP2C9 hydroxylation
activities are comparable with high NADH and low NADPH
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TABLE 5 | Monitoring peroxide production and reduced nucleotide consumption with controls.
Rxn. Peroxide at early time (nmoles/ml) Peroxide at later time (nmoles/ml) Consumption rate (nmoles/ml/min)
NADPH (10min) NADH (16min) NADPH (30min) NADH (33min) NADPH NADH
CYP + Diclof 0 0 0.89 ± 0.2 1.3 ± 0.4 0.13 ± 0.06 0.10 ± 0.01
3.8 ± 1.9 4.9 ± 0.9 nd
CPR + Diclof 1.96 ± 0.1* 1.0 ± 0.1 5.74 ± 0.4* 1.8 ± 0.7 0.74 ± 0.03* 0.12 ± 0.01
9.0 ± 0.5 14.2 ± 0.1 nd
CPR + CYP 2.64 ± 0.2 2.9 ± 0.1 6.32 ± 0.1 1.82 ± 0.2 0.90 ± 0.04 0.27 ± 0.03
12.7 ± 0.7 21.4 ± 0.3 nd
CPR + CYP + Diclof 3.44 ± 0.1* 2.1 ± 0.3 6.23 ± 0.1* 2.0 ± 0.5 1.08 ± 0.09* 0.37 ± 0.03
11.2 ± 0.5 18.1 ± 1.1 nd
[CPR] = 100 nM, [CYP2C9] = 100 nM and [Diclof] = 100µM. (The upper row in NADH reactions had 135µM NADH and the lower one had 1350µM NADH.) Rate of NADH depletion
was determined from the slope of linear fit of 340 nm OD at 0, 90 and 180min. The controls with CYP or CPR also included Diclof. For NADPH reactions, the initial concentrations of
components were–[CYP2C9] = 100 nM, [CPR] = 100 nM, [Diclof] = 200µM, and [NADPH] ∼200µM. NADPH depletion rate was determined from the slope of linear fit of 340 nm OD
at 16, 26 and 36min. The controls with CYP or CPR did not include Diclof. nd: not determined, *data previously reported in our work, given here for comparison (Manoj et al., 2010b).
TABLE 6 | Effect of reaction conditions on the utilization of reduced nicotinamide nucleotides and specific hydroxylated product formation.
Reaction setup Sampling at 15min Sampling at 60min
Reductant consumed Product formed Reductant consumed Product formed
NADPH NADH NADPH NADH NADPH NADH NADPH NADH
1. 2C9 + CPR 44.1 40.9 0.623 0.089 76.9 85.1 2.657 0.319
2. 2C9 + CPR + Cyt. b5 39.6 42.0 0.652 0.093 71.4 86.9 2.913 0.330
3. 2C9 + CPR + DLPC 29.5 28.8 0.761 0.107 71.1 72.5 3.522 0.406
4. 2C9 + CPR + Cyt. b5+ DLPC 28.5 25.7 0.930 0.154 70.0 65.2 4.078 0.638
5. Baculosomes 36.9 16.6 3.013 0.254 61.4 19.2 8.313 0.870
6. Baculosomes + Cyt.b5 33.3 nd 4.522 0.554 63.9 nd 15.61 1.971
Initial concentrations in reconstituted systems-[CYP2C9]= 170 nM, [CPR]= 600 nM, [Cyt. b5 ]= 40 nM, DLPC= 7.6µg/ml. In baculosomes, CYP2C9 concentration of 10 nM; [NAD(P)H]
∼180µM and [Diclofenac] = 200µM. Incorporation of Cyt. b5, DLPC and both to the CYP + CPR setup enhanced the reactions by 1.09 ± 0.07, 1.77 ± 0.06, and 2.55 ± 0.2-folds in
both NADPH and NADH reactions (at 15min). All concentrations are given in nmoles/ml.
concentrations (results not shown). In these reactions, though
NADH consumption was lower than NADPH, the extent of
peroxide formation was comparable for 100–200µM level of
reduced nicotinamide nucleotides. This is interesting to note
because at least in the initial time frames, the hydroxylation
activity is practically zeroth order with respect to NADPH (from
a few hundred micromolar to∼ten micromolar concentration).
In some preliminary experiments, the specific product
formation (yield, efficiency, temporal variations etc.) was studied
under different compositions of reaction components (substrate,
NADPH, Cyt. b5, etc.). The results are presented in Figure
S12, Supplementary Information. (The reported values therein
are good for relative comparison within a given experiment
and the absolute values should not be taken for comparison
across different experiments). In an experiment with equal
amounts of CYP2C9 and CPR (experiment 1, at a relatively
lower concentration of diclofenac), it was seen that incorporation
of Cyt. b5 had a “straightening effect” (which is partly
interpreted as prevention of secondary oxidations) on the curves.
Usually, the addition of Cyt. b5 had the effect of lowering or
enhancing the yield of product, depending upon the reaction
conditions (CYP:CPR ratios and CPR, NADPH, and substrate
concentrations were crucial determinants). This showed that all
these components contributed to multiple redox equilibriums
operating in milieu. NADPH was a better electron donor than
NADH (depending on the reaction compositions, it ranged
anywhere from a few folds to an order of magnitude), but
a higher concentration of NADPH was correlated to lowered
specific product in milieu (once again, interpreted to be
owing to increased secondary oxidations), particularly with the
progression of time. Table 6 shows the comparison of NADPH
and NADH as electron sources (at an approximately equimolar
starting concentration of both NAD(P)H and substrate), in
reconstituted and baculosome systems. The utilization rate of
NADPH and NADH were comparable in reconstituted systems
and yet, the hydroxylations were less efficient with NADH
in all systems. An initial surge or delay in NADPH/NADH
utilization was also noted in some reactions. Under these
reaction conditions, the incorporation of Cyt. b5 and DLPC
enhanced product formation and lowered NAD(P)H utilization
(and thereby, significantly enhanced “coupling” or product yield)
in reconstituted setups. In baculosomes, a greater distinction
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TABLE 7 | In silico analysis of binding of nicotinamide nucleotides with CPR.
Substrate
(log P)
[log D]*
Blind Docking Centered Docking
Lowest energy (kcal/mol) Distance (Å) Interactions Lowest energy (kcal/mol) Distance (Å) Interactions
NADPH
(−5.93)
[−12.2,
−12.86]
−2.01 9.4 TRP679
ARG570
−7.33 20.2 GLU482
ARG301
ARG600
LYS605
ARG570
ARG600
CYS569
SER599
LYS605
VAL606
TYR607
ALA597
NADP+
(−7.3)
−1.34 10.8 ARG570
ARG600
−7.50 11.7 ARG636
THR538
[−8.6,
−9.38]
ARG301
ARG570
ARG600
SER599
TYR607
NADH
(−4.35)
−3.10 9.0 TRP679
ARG570
−7.28 9.3 SER599
ARG600
[−9.1,
−9.17]
ARG600
ARG301
ARG570
LYS605
ARG301
VAL477
VAL478
TRP679
NAD+
(−5.72)
−2.07 17.1 TRP679
ARG570
−6.02 7.5 ASP641
TYR607
[−5.92,
−5.99]
SER680
VAL477
PRO536
ASP634
THR538
ARG600
ARG570
ASP575
ARG301
Distance–NAD(P)H reaction site and FAD reaction site; *log D values are given for two pH values of 5.5 and 7.4, respectively. Grid B-blind docking; Grid C-heme-centered docking.
was seen between NADPH and NADH, with respect to reduced
nucleotide utilization. This could perhaps be owing to a better
interfacial phenomenon in the baculosome systems, where
the enzymes are well-housed. At certain instances (in the
baculosomes), incorporation of Cyt. b5 shows an enhanced
utilization of reduced nicotinamide nucleotides and product
yield (particularly, at later reaction times), indicating an intricate
interactive dynamics of DROS evolution and utilization in
the system (result not shown). Also, the ability of DLPC to
affect diclofenac hydroxylation yield depended on the initial
concentration of diclofenac and the extent of breakage of
N-term of CPR (result not shown). Figure S13 confirms
the findings of Table 6, with another CPR preparation, at
comparable concentration terms of the reactants. Here too,
in the reconstituted system, incorporation of Cyt. b5 lowered
NADPH consumption (for example- from 15 to 60min of
reaction time, the setup lacking Cyt. b5 consumed 53 nmoles/ml
NADPH whereas the reaction incorporating the Cyt. b5
consumed 26.5 nmoles/ml). Here, we could note that in the
reconstituted setup, the incorporation of Cyt. b5 was not
beneficial in the early time frames for NADH reactions. This
signifies that in such a system, sequestering of the one-electron
equivalents by Cyt. b5 was deleterious for the specific product
formation.
We probed the in silico binding of nicotinamide nucleotides
with CPR and the results are given in Table 7. We could
not find a molecular explanation (based in structure-affinity
correlation) for the enhanced efficiency of NADPH (when
compared to NADH) as the electron donor (vis a vis CPR)
for the generation of specific hydroxylated product. Both show
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FIGURE 8 | Hydroxylation of diclofenac by a simple chemical control: Incorporation of NADPH enhanced rate and specificity. Initial conditions were- [Ferric
citrate] = 1µM, [H2O2] = 400µM, [diclof] = 200µM, [NADPH] = 200µM, ∼OH Diclof area = 45/µM. (A) Effect of pH (without NADPH). (B) Effect of NADPH (at
pH 7.4).
comparable binding energies and in fact, NADH shows better
orientation and energy differences between the reduced and
oxidized forms (thereby facilitating a dissociation of the oxidized
product).
Simple chemical controls employing a high redox potential
insoluble Fe (III) species (at the physiological pH 7.4) gave small
amounts of hydroxylation of diclofenac, a CYP2C9 substrate. The
results are shown in Figure 8. Increasing the pH from 7 to 8
gave a slight increase in hydroxylation efficiency (contrary to the
enzyme activity). At pH 7.4, at initial time frames, the control
reaction (without NADPH) had ∼31% of the specific 4′OH
diclofenac whereas the test reaction (incorporating NADPH)
had ∼46% of the specific product. The presence of NADPH
increased reaction rates for the specific 4′OH product by a factor
of 6.5 and the total hydroxylation rates were enhanced by a
factor of 4.4. Another set of reactions were done employing
1µM FeSO4/dil. acid (where more ferrous ions could be better
stabilized), at 1mM NADPH, 200µMH2O2 and 100µMDiclof.
Results for this (not shown) also revealed that NADPH + Fe
+ H2O2 combination showed greater hydroxylation rates and
specificity (when compared to Fe + H2O2) for 4′OH diclofenac
formation for short/longer incubations. Therefore, these simple
chemical controls showed that hydronium and hydroxyl ions
from the reaction milieu and reduced nicotinamide nucleotides
could also play significant roles in instilling specificity and
enhancing rates of hydroxylation (quite akin to the dual function
of chloride ion in chloroperoxidase chlorination milieu; Manoj,
2006).
DISCUSSION
The outcomes of this work indicate multiple one and two
electron redox equilibriums in the milieu involving NADPH,
substrate, DROS, enzymes, etc.; quite akin to other heme-enzyme
paradigms that we recently established (Manoj, 2006; Manoj
et al., 2010a, 2016b). Now, we attempt to provide explanations
to the overall phenomenology of CYP reactions. Before reading
any further, it is strongly advised that the reader familiarizes with
the critical dissection of the erstwhile hypothesis and the original
proposal we made on murburn concept in Venkatachalam et al.
(2016).
Dynamics of ROS in milieu
The dynamics of peroxide in milieu can be better explained
by the oxygen activation and peroxide depletion ability of CPR
(Manoj et al., 2010b), the interactive dynamics of superoxide +
peroxide in milieu and from the results of controls investigated
in the current study. The water formation at heme-center by
Compound I (Grinkova et al., 2013) remains a highly improbable
and unproved proposal. A highly reactive electron-deficient
intermediate need not wait indefinitely for two protons and
two electrons in the highly hydrophobic lipid layer, in order to
form water. It is clearly established that a CYP like 2C9 has
limited peroxide utilization ability and it serves primarily as a
one-electron species (like superoxide) stabilizer. The controls
employed in this study clearly show that the concentration and
temporal variation of peroxide formation in milieu is modulated
by diverse factors and is contingent upon the type of substrate
present, even without CYP’s presence. Even though a high
amount of superoxide was introduced into aqueous phase, within
the first minute of the reaction, the majority of ROS were
converted to water, and only a small fraction of peroxide was
observed. Also, since peroxide levels were higher in substrate
+ superoxide combinations, it implies that substrate interaction
or reaction with reactive species could also facilitate peroxide
generation. A high spin iron center could easily flip the triplet
oxygen to singlet state, which could react fast with the flavin
of CPR to give peroxide. This could afford an explanation
for the increased consumption of NADPH (and elevation of
peroxide levels) upon the incorporation of CYP into the CPR +
NADPH reaction. The involvement of hydroxyl radical or singlet
oxygen cannot be ruled out in an aqueous system containing
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metal/flavin centres, triplet oxygen, superoxide and peroxide.
From the data obtained herein, the semiquinone state of the
flavin seems to be crucially involved in CPR mediated catalysis.
The temporal variations in ROS, products etc. are thus well-
accounted by the murburn concept. The erstwhile hypothesis’
iron-center based ROS production fails to account for the ROS
dynamics observed. Higher concentration of CPR would give
greater DROS, which would react amongst themselves and
therefore, a low concentration of CYP cannot compete effectively
for stabilization of the radical species. HRP can effectively
utilize the DROS at the phospholipid interface whereas SOD
removes the superoxide only from the free aqueous phase and
cannot compete with the CYP at the phospholipid interface. The
utilization of DROS to hydroxylate the substrate or dissipation
to water formation serves as an electron sink, which leads to a
redox pull, which in turn releases more electrons from NADPH
(via CPR).
Roles of Nicotinamide Nucleotides
The most essential aspect of the murburn concept is that CYPs’
crucial role lies in stabilizing the one-electron equivalents spewed
by CPR within the phospholipid bilayer and maintaining “a one-
electron, radical reaction paradigm.” Clearly, the zeroth order
depletion of NADPH in CYP reactions (Manoj et al., 2010b; and
this work) and the ability of NADPH to enhance rate/specificity
of product formation in chemical controls signifies a diffusible
radical reaction. The second electron is readily available from
NADPH, or other radicals/peroxide in milieu.
The experimental evidence shows a comparable depletion
rate for both NADPH and NADH, at least in some systems.
Also, the in silico exploration gave no evidence for the enhanced
effectiveness of NADPH for the hydroxylation activity. The
answer to this conundrum must lie in the physical nature of
NADPH/NADP+ redox couple (and their partitioning per se),
and not in its interactive ability with CPR. From the theoretical
considerations, a few inter-related aspects are noted that favor
NADPH-
1. Redox potentials: NADPH couple has ∼5mV lower two-
electron redox potential than NADH couple and this value can
go up in the physiological milieu owing to distribution of the
nucleotides in the cell.
2. Partitioning effects: NADPH has∼3 units of log D (at pH 7.4)
and∼1.5 units of log P lower than NADH.
3. Catalysis by protons: The difference between the pKa of the
two molecules- i.e., the difference of log D at pH 5.5 and pH
7.4 of NADPH is 0.6 units whereas that of NADH is only 0.06
units.
4. The phosphate group of NADPH (or an intermediate/product
thereof) may be involved in charge stabilization of the reactive
intermediate (which is involved in the final product formation
from substrate). Further, the phosphate group of NADPH
could aid proton delivery in a crucial step that occurs in free
milieu (or interface).
Our observations show that the nicotinamide nucleotides affect
DROS profiles and secondary oxidations, which can be essentially
understood to occur in the aqueous phase. This supposition is
also strengthened by control reactions where addition of NADPH
lowers side reactions of superoxide and from the observations
that excesses of NADPH is deleterious to the yield of product
(results not shown). Further, it is also known that NADPH
addition in bulk or production via a regenerating system affects
ROS/Cyt. b5 dynamics and product hydroxylation efficiencies
(Porter, 2002; Schenkman and Jansson, 2003; Kumar et al.,
2005). Since CPR, CYP and hydrophobic substrates are generally
localized in the microsomal membrane, we can safely surmise
that the first electron transfer and substrate activation step must
occur at the phospholipid interface. We can now infer that
the nicotinamide nucleotides could be involved in at least two
discrete one-electron steps. Therefore, NAD(P)H plays multiple
roles by virtue of its interaction with CPR, ROS and diffusible
substrate-centered radicals.
Protein Distribution and Interactions
The erstwhile hypothesis involves protein-protein interaction
and long-range electron transfers, which is still a gray area
in biochemistry (Gray and Winkler, 2003; Moser et al., 2008).
The scheme for the same involves collision, conformational
gating and subsequently, the actual electron-transfer process. The
time required for the movement of electrons across a maximal
distance of 12 ± 2 Angstroms (approximately 20 bonds) is
in the range of milliseconds. The process gets inefficient with
increasing distances too. Such a process cannot be efficient
between bulky proteins in the highly constrained and low-energy
microcosm of phospholipid membrane. This would require a
high concentration of CPR for effective catalysis; also, we would
expect better catalytic turnovers and product yields with a high
CPR:CYP ratio. However, our works show quite a contrary effect.
The well-known poor distribution density of CPR (1 CPR to
∼100 CYPs) within the liver microsomes and the promiscuity of
CPR (a unique CPR can transfer electrons to hundreds of CYPs)
can now be efficiently explained with the murburn concept. A
higher CPR:CYP ratio would not be evolutionarily desirable,
since it may lead to a high rate of DROS generation, depletion
of redox equivalents and cause too many secondary oxidations.
Therefore, the presence of CPR at low concentrations is an
evolutionary requisite. If the substrate does not leach out from the
membrane after one-step oxidation and continues to persist near
the lipid bilayer, secondary oxidations (in due time, even with
lower CPR concentrations) would ensure that it would become
more polar, thus causing its removal from the vicinity of the
membrane. The error bars are bigger for reconstituted systems
with higher CPR (particularly at later time frames) because of
the greater amounts of chaotic ROS involved. The very notion
that processes featuring a diffusible intermediate are always
chaotic is misplaced. One of us has shown in CPO’s chlorinating
mixture that at a lower concentration of a diffusible reactive
agent, one can get fairly reproducible and non-chaotic specificity
(Manoj, 2006). Subsequently, we have established that electron
transfers by diffusible agents are highly reproducible (Manoj
et al., 2016a). Further, the same idea has been demonstrated in a
simple chemical control for diclofenac hydroxylation in this work
(Figure 8).
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It is noteworthy that till date, there exists no direct
experimental evidence or justification regarding the necessity of
CYP-CPR complexations for the overall catalysis in a dynamic
state. The existence/elucidation of various homo- or hetero-
oligomers in CYP-CPR mixtures is not questioned, but the
obligatory relevance of the same in the overall catalysis appears
to be doubtful. The deleterious effect of higher ionic strengths
or mutations of key amino acids on the overall reaction
(Voznesensky and Schenkman, 1994; Shen and Kasper, 1995)
cannot be interpreted to be because of a disruption of electrostatic
interactions between CYP and CPR alone. In the work by
Shen et al. (Shen and Kasper, 1995), the electron transfer rates
increased sharply when ionic strength was increased at lower
concentration ranges. We have confirmed this with experiments
on Cyt. c reduction by intact CPR. Since pH is the primary
determinant of the charged states of the amino acids touted to
play roles in CYP-CPR interactions, enhancement of activity at
lower ionic strengths does not go well with a protein-protein
complexation process. It goes perfectly well with the concept
that diffusible species (including ions) mediate electronic relay
in these heterogeneous systems. Mutating residues located far
away from the active site (even amino acids located on the
surface of the protein) significantly affected the catalytic rates
in a heme-thiolate protein (which did not require protein-
protein complexation) like chloroperoxidase (Rai et al., 2000).
The ability of various amino residues’ (located far away from the
heme-center) to modulate ROS (or the “flow” of such species
thereof) have been discussed earlier in our works (Gideon et al.,
2012; Venkatachalam et al., 2016). So, the effects attributed to a
disruption of putative protein-protein interaction by mutation
studies can be explained by other considerations also. The data
presented in Figures 4–7 and Tables 2–3 argue against the roles
of binary complexes of CYP and CPR in routine in vitro or in
vivo scenarios. There are several examples for such non-specific
interactions in the literature (Granvil et al., 2002; Lu et al., 2003;
Oshima et al., 2004; Kumar et al., 2005). While the murburn
concept poses no conflict with such observations, application of
the erstwhile hypothesis for explaining such data mocks Occam’s
razor. The different proteins/molecules substituted in lieu of
the original protein have little structural homology with the
latter. Diffusible species (like superoxide) can be a source of
activation, leading to CYP-specific product formation, whereas
the dismutated product (peroxide) is less effective. This inference
is supported by our own observations, in control experiments
where peroxide concentration in milieu was monitored after
addition of superoxide to the solution containing only the
substrate (Results Section and Supplementary Information,
Figure S2). When CYP molecules are absent from the vicinity
of CPR and when the latter releases superoxide, one- electron
equivalents, the lifetime of the reactive species is very low because
the components of milieu may consume them or they may react
amongst themselves. A similar phenomenon is seen in CPO’s
chlorinating mixture where the diffusible reactive intermediate is
taken up by the reaction components themselves, in the absence
of a suitable substrate (Manoj and Hager, 2001, 2008; Manoj,
2006). Therefore, it can now be understood that the same CPR
can promiscuously “reduce” (or transfer electrons) to a hundred
different CYPs, cytochromes and other small molecules only
because the interaction is mediated via diffusible species.
Roles of Phospholipid Bilayer and
Cytochrome b5
Clearly, the effects of partitioning and distribution of ROS and
radical scavengers are evident in the reaction systems. The
hitherto held belief was that Cyt. b5 serves as a direct electron
donor to the CYPs in certain cases and in some others, it serves as
a conformational modulator of CYPs (Porter, 2002; Schenkman
and Jansson, 2003; Guengerich, 2005; Kumar et al., 2005). Both
solicited protein-protein complexation as the modalities for this
electron transfer. We have observed that Cyt. b5 either enhances,
lowers or minimally perturbs the hydroxylation efficiency in
the CYP2C9 (Table 6 and Supplementary Information Figures
S12, S13) and CYP2E1 (Manoj et al., 2010a; Gideon et al.,
2012) systems, depending upon slight or major variations in
the overall reaction components’ composition. This is backed
by literature (Kumar et al., 2005). Changing the reductant
from regenerating NADPH system to providing an initial high
concentration of NADPH also gives different effects (Manoj et al.,
2010a). The erstwhile hypothesis cannot account for the lowering
of hydroxylation efficiency with increasing Cyt. b5 because if
the latter served as a protein-protein electron transfer shuttler
(which is a rate-limiting step in the erstwhile hypothesis), the
hydroxylation efficiency should only be increased by increasing
the Cyt. b5 concentration.
CYP, CPR, and Cyt. b5 are membrane proteins whereas
proteins, quite unlike the hydrophilic Cyt. c and NADPH.
Partitioning of components is introduced by DLPC and it plays
a crucial role in reaction outcomes. Increasing or decreasing
concentrations of any species brings in discontinuity in effects
and heterogeneity in distribution (as exemplified by aggregation
and micellization at one hand and enhanced stability of some
radicals at low concentrations in selective niches, on the
other hand). Our recent work solved the role of the N-term
transmembrane segment of CPR in CYP reactions, explaining
that the detached transmembrane N-term segment has DROS
modulating abilities (Gideon et al., 2012). We have recently
demonstrated that redox additives could enhance electron
transfers in heme-enzyme mediated reactions by serving as non-
specific agents for redox relay (Gade et al., 2012). Therefore, it
is opportune to see diffusible radicals in heme-enzyme systems
as functionally relevant agents that bring in both chaos (at
high concentrations) and order (at lower concentrations). Cyt.
c and Vit. C can affect P450 mediated catalysis, as shown
in Figure 6 and Figure S6 (supplementary Information). It
is under this light that the role of Cyt. b5 can be better
understood. One-electron equivalents generated by CPR are
transiently stabilized by Cyt. b5, which in turn could shift the
CPR mediated equilibrium (oxygen–superoxide) to the right, to
some extent. Further, Cyt. b5 could serve as a “dynamic storage
port,” accepting an electron from superoxide (at high superoxide
concentrations), retaining the one-electron equivalents in the
lipid phase and releasing the electron to an oxygen molecule (at
low superoxide concentrations). This is quite probable, because
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the redox potential of Cyt. b5 is much lower (approximately
+25mV; Porter, 2002; Schenkman and Jansson, 2003) than
that of Cyt. c (+260mV). But it is inefficient at giving the
electron to CYPs because of their relatively lower redox potentials
(Margalit and Schejter, 1973) and poorer mobilities of both
proteins. The crux of the issue is the availability of superoxide
to CYPs within the kinetically favorable time frame. If the
rate of release of electron is commensurate with the rate of
CYP mediated hydroxylation, we would observe a positive effect
on CYP hydroxylations. On the other hand, if excess Cyt. b5
sequesters the electrons amongst its own kind (or catalyzes futile
reactions) and if the reaction mediated by CYPs occur faster than
oxygen to superoxide conversion (brought about by Cyt. b5),
then CYP hydroxylations would be lowered. This analysis could
explain how the inclusion of Cyt. b5 lowers peroxide formation in
many reactions. Occam’s razor does not favor the interpretation
that Cyt. b5 brings about subtle changes in the conformations
of certain CYPs (and that too, in a manner dependent on
concentration!). Therefore, the effect of Cyt. b5 is contingent
upon the type of CYP and its concentration, the amount of
CPR, the lipid, substrate concentration, etc. We have already
shown that substrate sponsored inhibitions can be affected by
Cyt. b5 (Figure S12, Supplementary Information andManoj et al.,
2010a). Increasing lipid concentrations only lowers the electron
transfer rates from CPR to Cyt. c (Manoj et al., 2016a). This
means that the effective DROS concentration (for interacting
with Cyt. c) is lowered and the DROS produced may not find
Cyt. c in its immediate vicinity. Therefore, it is clear that the
phospholipid bilayer serves to bring CYP and CPR in proximity
to each other (and their hydrophobic transmembrane segments
aid in achieving this mandate; Gideon et al., 2012) and keep
the small amounts of DROS restricted around the membrane.
We can now deduce that a CYP like 2E1 has a more fastidious
requirement for Cyt. b5 because it does not have large channels
to the heme-center and it depends on Cyt. b5 to keep the one-
electron equivalent “credited” within the protein systems, thereby
not leading to peroxide or water formation.
But What about Compound I?
Very importantly, the work leads us to infer that the two-electron
deficient Compound I cannot be the preponderant active species
for CYP catalysis. Compound I is known to be spontaneously
formed in peroxidases [that have acid-base or polar catalytic
residues (with dissociable protons) in the distal pocket], at
very high concentrations of the enzyme and peroxide, with
heterolytic scission of the peroxide. Formation of a Compound
I in microsomal CYPs via homolytic scission of oxygen-oxygen
bond is not demonstrated yet. The claim made by Green’s group
(Rittle and Green, 2010) does not stand good for microsomal
CYPs because CYP119 has a highly polar distal pocket with three
threonine residues. Moreover, the generation of the two-electron
deficient intermediate was done with a peroxyacid, which would
make facile the heterolytic scission.
A high potential intermediate generation cannot be achieved
by the cellular system in such a manner. The “remarkable”
findings in our group’s work (Manoj et al., 2016b) is conclusive
evidence for the statement that a one-electron process is the
more favorable thermodynamic route, particularly given the low
mobility phospholipid environment. (P450BM3 reactions are not
to being considered in the discussion here because it is a very
different enzyme!) We have clearly demonstrated that at low
concentrations of heme-enzyme (in a few nM to tens of nM
ranges) and peroxide (in a few hundreds of µM ranges), there
is little probability of the peroxide accessing the active site to
form Compound I in the most well-known of peroxidases. As we
increase the size of hydroperoxide, the catalatic rate decreases in
CPO. This result showed the size/diffusion limitations induced
by an active site process (Manoj and Hager, 2001). Since CPO
has a relatively easily accessible and larger active site (and the
reaction pH is more acidic), it depletes hydroperoxides better
than HRP through the two-electron Compound I route. (It is
strongly advised that the reader goes through the pertinent results
and discussion of these earlier papers from our group). CYPs
do not have a highly polar distal pocket and as a result, they
stabilize a DROS like superoxide (and consequently, peroxide).
This inference is amply supported by the pioneering works of
Blumenthal and Kassner (1979).
Martin Newcomb was probably right earlier when he doubted
the involvement of Compound I as the sole oxidant (Newcomb
et al., 2000, 2003). Here are some more reasons why [other than
the ones quoted earlier herein and elsewhere (Venkatachalam
et al., 2016)]-
1. Till date, there is no evidence that Compound I is relevant in
routine assay or physiological reaction conditions for CYPs
(particularly, for the hydroxylation of non-activated carbons,
which the CYPs are famous for!).
2. There is no peroxidase dismutation activity observed in major
CYPs, like CYP2C9 (Manoj et al., 2010b), which is a simple
feature expected of Compound I species, well-demonstrated in
heme peroxidases. (Surely, peroxide being small, should act as
an efficient substrate for CYPs, which can act on such diverse
and relatively lesser reactive molecules!).
3. Heme-peroxidases (demonstrated to have Compound I, like
CPO) show oxygen insertions of activated carbons only,
and give poor efficiency for hydroxylations of non-activated
carbons. This shows that Compound I may not have the
potential to hydroxylate non-activated carbons.
4. Size and orientation of substrate are not a major constraint
to most CYP mediated oxygen insertions but it is an issue
with a Compound I species of heme-thiolate enzyme like CPO
(Lakner et al., 1997).
5. CYPs swing both ways- carry out oxidations and reductions.
This shows a one-electron species role. It is highly unlikely
that a two-electron deficient electrophilic Compound I could
mediate reductive reaction cycles.
6. Optimized enzyme reactions give microsomal CYP activities
with pseudo-first order rates of substrate conversion at 1 per
second, when nM levels of CYPs are used in the reaction. If
we assume that collisions are at least one order slower in the
lipid phase, we are left with a reaction rate that is 10 times
higher than themaximum achievable collision rates achievable
by such low CYP concentrations. When we consider that time
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would be taken for the large substrates to diffuse into the
heme pocket (for which the F and G loops open in millisecond
time frames) and electron transfer across distances of >10
Å become less probable (and which too require greater than
millisecond time frames), we cannot explain the reaction
outcomes with multiple molecules’ repeated affinity-based
complexation process.
Therefore, there are very strong points to argue that a Compound
I species formation via homolytic scission with NADPH + CPR
+ O2 combine (going through the erstwhile mechanistic route,
as shown in Figure 1A) is highly improbable. We speculate
(forthrightly!) that it is also highly unlikely that CYPs could form
Compound I, even with ROS species like peroxide or superoxide
as starting material, particularly with nM levels of CYPs. To
us, the probability of small molecule access to heme-center
appears kinetically challenged in low enzyme concentrations
(Parashar et al., 2014b) in the phospholipid microenvironment
and the oxidase (Fenton-like) radical pathway seems more
probable. (Disclaimer- The scenario may be different in
highly concentrated synthetic chemistry setups and spectroscopy
sample preparations!).
When it is known that a CYP can kinetically differentiate
between an R and S enantiomer of a substrate (Oguri et al., 1994;
Kaminsky and Zhang, 1997), it is highly unusual that most of the
human liver microsomal hydroxylations are not enantioselective.
(There are exceptions like benzylic hydroxylation of Bufuralol-
CYP2D6, which can be explained by considering that the heme-
iron active site in such an enzyme is easily accessible through a
canal and the locus of hydroxylation on the substrate molecule
is not geometrically/sterically hindered. Further, the relevant
carbon has higher electron density, or is activated. It is interesting
to note that even in such cases, the reaction is not regiospecific,
as significant aromatic hydroxylation is also noted). This is quite
unlike CPO catalyzed epoxidations of benzylic centers where
high enantioselectivity is coupled with high yield (Allain et al.,
1993). If one considers that the heme-floor forms the ground
for all CYP reactions, it is practically impossible to imagine why
a substrate should bind enantioselectively but not react in the
same manner (if binding is a relevant and required facet, as the
erstwhile hypothesis seeks). It is impossible to imagine how some
occluded loci of a substrate molecule can be accessed by a heme-
oxygen reactive intermediate. Hitherto, researchers reconciled
with the lack of enantioselectivity observed with large substrate
molecules and the small intramolecular KIEs in similar substrate
molecules (of comparable dimensions). [The latter was attributed
to masking! This means that the substrate is not free to rotate
in the active site and is relatively restrained in one way. If it
is restrained, then there is binding (which is what the erstwhile
hypothesis seeks) in a particular orientation and this should give
enantioselectivity! We seem to run into incongruities with the
erstwhile hypothesis every time!] Enantio- specificity/selectivity
(in terms of kinetic preference of a substrate enantiomer OR
differentiation of enantiopic faces of the substrate leading to
enantiomeric excess of a product) can be afforded even if the
substrate bound and reacted at a locus distinct from the heme-
Fe center. (However, highly enantioselective reaction product
formation is definitely a strong case for heme-centered Fe-O
species. This can be achieved for efficient CYPs like P450BM3
and other CYPs with non-occluded channels with suitable small
molecules, and that too, only at high concentrations of enzymes
and substrates).
Therefore, to keep things simple- the hunt for the
protagonist(s) in the context would lead us to three candidates-
two-electron (Fe-peroxyl), one-electron (Fe-superoxyl) or
uncharged radical (Fe- hydroxyl) species of oxygen stabilized
at the heme-center. When there is little enantioselectivity
and when the enzyme/reactants are in a diluted state (as
most lab assays or physiological conditions are), a diffusible
superoxyl/hydroxyl radical species serve as good candidates to
explain for all observations hitherto available on CYPs. These
have the potentials and these can gain access to remote regions of
the substrate molecule. In reactions where LFE correlations give
a positive slope with increasing sigma values (that is- the reaction
is inversely dependent on the electron density on the substrate
or the transition state is negatively charged), superoxide species
based reaction scheme seems more probable. Most importantly,
such species work in conjunction with NADPH or even two
one-electron species could be involved in two distinct steps
(since the radical reactions need to be quenched, finally!). A
cationic species can also be involved, depending upon how the
reactive intermediate forms a stable product. If this species’
interaction is rate limiting, we could get its signature also in
the overall scheme. Highly enantioselective reactions (with high
yields) would most probably have the Fe-peroxyl species reacting
with activated centers on the substrate (within the distal active
site) or the diffusible radical species reacting with a tightly bound
substrate (anywhere on or around the enzyme).
Cytochrome P450s: What Are the Issues
with the Past and What Should Be
Unlearned for the Future?
A question that Fred Guengerich had asked a decade back
(Guengerich, 2004) should be unabashedly rephrased as above.
It is not a worthwhile endeavor to bank on the absolute values
of classical kinetics/equilibrium constants (kcat, KM, Ki, Kss or
Kis or the likes) for CYPs. They mean very little because they
do not hold the erstwhile theoretical relevance and they may
vary by orders of magnitude, based on the initial and evolving
reaction conditions. (When a molecule serves as an activator and
inhibitor, and that depending upon concentration, to the same
given enzyme; and when this phenomenon is seen too often,
with not just a unique additive or substrate, it is high time to
move beyond the Michaelis-Menten paradigm to interpret such
effects). It is not a good idea to debate over the “rate limiting
step” or “a unique catalytic species” in CYP catalytic cycle
anymore. There could be any number of processes and molecules
that would be operative, which in turn, can easily be envisioned
to be dependent on initial assay conditions. It would be a good
idea to start getting more statistical information from clinical
or in vivo research or at least, we should employ microsome
preps for getting a more reliable picture of what could really
happen. (We should not use baculosomes or reconstituted
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systems to pinpoint and portray the dynamics within the liver
microsomes). The results from in vitro should not be used
with high confidence to project the outcomes in vivo or in
situ. This is because the presence of a trace amount of a small
molecule can alter the whole kinetics, as we have shown with
the reductionist approach. It is feasible to predict what position
a substrate might get hydroxylated at, but more important is
the interaction of intermediates formed, rate of “excretion” and
toxicities of the side-products. The redox potentials of different
drugs, their dynamic concentrations in the liver cells and
their logP/logD facets, their known affinities/mechanism based
inhibitions of select enzymes if any, the extent of glycogen/fat
deposits within the liver, etc. should be considered pivotal in a
case-wise modeling of drug interactions involving CYPs. It is
crucial to remember that not mere genetics govern metabolic
predispositions in the liver, it is the reaction microenvironment
that plays a greater role in CYPs’ reactivity. More reliable liver
models would be needed for phase I drug metabolism research
in the times to come. In that regard, it is very important to
profile the small molecules in liver microsomes/cells and gauge
an impact of their activities on CYP mediated metabolism. No
molecule sits as a spectator when a CYP goes to work. Quite
simply, the CYP+CPR combo is too hot for that to happen! In an
earlier communication, we had shown how the dynamics of the
metabolism of a particular substrate (diclofenac) changes upon
the incorporation of a “so-called inhibitor” (dihalophenolics)
in two setups- baculosomes and microsomes (Parashar et al.,
2014a). The pertinent data is presented in Supplementary
Information, Table S2. It could be seen clearly therein that
while benzbromarone and benziodarone inhibited both CYP2E1
and CYP2C9 in baculosome setups (containing only the
respective isozymes as the functional agent), the more “realistic”
microsome setups were activated (for diclofenac metabolism)
upon the incorporation of at least some concentration range
of these “arones.” Several small molecules activated the
CYP2C9-diclofenac reactions at lower concentrations, when the
same molecules served as inhibitors at equimolar concentrations.
Quite evidently, the currently available theoretical understanding
cannot be applied to generate inhibition constants
obtained from in vitro studies (either pure reconstituted or
baculosome systems) and such constants’ relevance cannot
be extrapolated to the complex functional roles in liver
microsomes.
We support the statements above with a simple experiment.
CYP2E1 and CYP1A2 can de-ethylate 7EFC (left panel of Figure
S14, Supplementary Information), though the efficiency varies
at different concentrations of the enzymes. When cholesterol
was added to CYP1A2-7EFC, the IC50 values were ∼1.03µM
and ∼170 nM, respectively, at 2.5µM and 5µM EFC (right
panel of Figure S14, Supplementary Information). The assay with
5µM 7EFC (a concentration much higher than the supposed
KM of <0.1µM; Code et al., 1997) afforded a Ki <3.5 nM (as
calculated from the IC50 value, using Cheng-Prusoff equation;
Yung-Chi and Prusoff, 1973) for cholesterol with CYP1A2. How
could this be, when cholesterol shows (in silico) binding with an
estimated Kd of ∼7µ M, a value which is several orders lower
than the (in silico) binding affinity of 7EFC for the very same
enzyme (CYP1A2)? This is counter-intuitive with respect to the
prevailing ideas of binding-based inhibitions and is quite similar
to inhibition of CYP2E1 by an agent like 4-methylpyrazole
(Parashar and Manoj, submitted). Table S3 (Supplementary
Information) shows that a heme-centered binding (docking)
does not explain the observations. We have demonstrated that
diffusible radical mediated inhibitions could afford such effects
in P450/peroxidase systems (Parashar et al., 2014a,b). CYP2E1 is
a heme-thiolate enzyme that does not have a readily accessible
channel to the heme distal center (Porubsky et al., 2008), when
the static structure was analyzed with PyMol. Recently, we had
postulated and demonstrated that catalysis in these systems is
mediated via diffusible species (Venkatachalam et al., 2016) and
(Parashar and Manoj, submitted), Along the same lines, the
crystal structure of CYP1A2 (Sansen et al., 2007) also does not
show a readily accessible channel to the heme-center. So, it is
only forthright to deduce that the mechanism of this enzyme also
follows the same route as CYP2E1.
Further, it is noted that the much celebrated CYP inhibitor,
aminobenotriazole (ABT) does not arrest enzyme activity
by heme binding but causes a sort of “mechanism-based”
inactivation (via the reactive benzyne formation; de Montellano
et al., 1984). That is- ABT is an efficient substrate (nucleophile)
whose oxidation leads to a reactive product that could diffuse and
oxidize the heme- edges. It is somewhat similar to how a terminal
olefin “mechanistically inhibits” CPO at high enzyme- additive
concentrations (Debrunner et al., 1996). We had demonstrated
that this inactivation is not seen when the enzyme is taken at
nanomolar concentrations (Manoj and Hager, 2008). CYP2C9
is very poorly susceptible to ABT (Emoto et al., 2003) and this
may be because its heme edges are not available for the reactive
species. This inference is supported by CYP2C9’s crystal structure
(Williams et al., 2003). Therefore, much care should be exercised
before attempting to device molecules for binding at the heme-
center (aimed to inhibit catalysis at low concentrations of the
enzyme).
Most substrates metabolized by a given CYP fail to induce
the particular CYP. This seems quite rational, given their
evolutionary mandate. Microsomal CYPs and the associated
cellular machinery have no evolutionary “clue” about what
substrate they would come across and would have to catalyze.
So, nature produced a bevy of CYPs with diverse surface
topographies and channel orientations. A substrate could either
bind on the surface or interact through direct reduction. A
diffusible radical stabilized within the heme pocket would emerge
out and it could chance to meet the substrate molecule localized
in or around the channel. The murburn hypothesis also explains
why antibodies to a particular CYP can knock out the activity
of that particular CYP in liver microsomal preparations. The
murburn hypothesis explains both well-coupled and uncoupled
P450 systems (in vitro or in situ). The proteins and substrates
need to equilibrate before the reaction commences (and the
dynamics of ROS varies into the reaction owing to the multiple
equilibriums involved) and as a result, we could have a product
forming at a higher rate after some time into an incubation
too. (If some worker observes this, it should not be considered
an artifact!) Hydrophobic proteins need several minutes of
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pre-incubation for effective catalysis. This means that the
mobility and equilibration of these proteins is a very slow process,
with respect to the overall kinetics.
CONCLUSIONS
It is now opportune for us to move out of the “esthetic concern”
that reactions involving reactive diffusible species (whether
generated by CPR, indirectly produced in the milieu or formed
by one-electron redox catalysis of the substrate) are chaotic.
These are non-specific only when such reactive species are at
much higher concentrations. For the critical reader, Table S4 of
Supplementary Information presents an itemized comparison
of the erstwhile hypothesis with the murburn concept. It can be
seen that murburn concept is fully accommodative of all aspects
known of CYP systems till date, whereas the erstwhile hypothesis
fails to explain a bevy of observations and considerations. The
murburn concept also explains the unique CPR’s promiscuous
ability to serve as electron donor to diverse CYPs and the
versatility of CYPs (diverse xenobiotic substrates need not have
high affinities for CYPs’ heme-pockets for them to be reacted
upon!). This manuscript ratifies several predictions/projections
(Venkatachalam et al., 2016) of murburn hypothesis and
lays foundations to some novel “cellular biochemistry”
concepts:
• Aside their roles as molecular messengers and as disruptive
agents in immunological responses against pathogens,
diffusible reactive oxygen species (DROS, exemplified by
superoxide radical) have been deemed as (patho)physiological
manifestations of oxidative stress. The current work
establishes that small amounts of diffusible radicals are
generated in situ as an obligatory part of routine redox
metabolism in liver microsomes. The findings confirm that
reactive diffusible radicals like superoxide are involved as a
catalytic requirement for routine housekeeping metabolism
within cells. Such processes could even have been one of
the major reasons for the success of the diradical molecular
oxygen’s evolution as a key protagonist in life processes,
per se. Contrary to the prevailing thought paradigms, two
sequential one-electron transfers may be quite ’normal’ in
cells. Electron transfers (for sustaining life and generating
or stripping reducing electron-equivalents) in cells evolved
obligatorily requiring the lipid fabric/platform to slow down
the radical process. Further, proteins like Cyt. b5 are now
understood to serve as steady-state “electronic buffers” in the
phospholipid system. The fact that diffusible radical species
(DROS, metabolites) are obligatorily involved in routine
metabolism could explain both normal and idiosyncratic
hepatotoxicity of drugs.
• Hitherto, enzymes are known to achieve rate enhancement
(catalysis) via the formation of a “transition state” that
entails a direct bond formation between the enzyme and
reactant(s) OR between the reactants themselves. Cytochrome
P450s catalyze xenobiotics’ metabolism without invoking the
erstwhile “transition state” concept (“lock and key”/“induced
fit” theories). Herein, the reaction locus may be delocalized
(uncertain) but is confined to the enzyme because it stabilizes
the otherwise short-lived radicals.
• When redox equivalents are utilized for substrate
hydroxylation in a well-coupled system, the oxygen-
superoxide equilibrium gets shifted to the right, leading to the
depletion of NADPH. In an uncoupled system, a similar tug
is exerted by the formation of water from DROS. Therefore,
the operating logic is a constitutive redox pull, same as that
established in the peroxidase milieu (Manoj et al., 2016b).
We envisage that the findings and ideas revealed herein
stand to usher in a new research paradigm in cellular redox
biochemistry. The outcome of this work necessitates that
new theoretical/quantitative approaches should be employed to
address CYP reactions and also seeks that textbooks should be
rewritten to abrogate the redundant ideas in the field.
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